PTCT peer analysis
PTC Therapeutics (PTCT) against its competitors: price, today's move, 1-year return and market value side by side.
PTCT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BBIO BridgeBio Pharma | $74.31 | -0.85% | 17.26% | $14.60B |
| BMRN BioMarin | $53.67 | -8.27% | 3.39% | $11.33B |
| CAPR Capricor | $7.32 | 14.73% | 5.78% | $370.93M |
| DYN Dyne Therapeutics | $17.30 | 3.68% | -26.52% | – |
| IONS Ionis Pharmaceuticals | $41.21 | -5.31% | -44.44% | $7.23B |
| KRYS Krystal Biotech | $295.74 | -11.00% | 56.41% | $9.84B |
| RARE Ultragenyx | $16.32 | 1.37% | -53.60% | $1.59B |
| SLDB Solid Biosciences | $6.20 | -2.97% | 16.76% | $664.80M |
| SRPT Sarepta Therapeutics | $18.32 | -1.64% | -21.23% | $1.97B |
| WVE Wave Life Sciences | $3.59 | -1.10% | -56.75% | $708.05M |
| PTCT PTC Therapeutics | $60.84 | 1.45% | -10.67% | $5.01B |
- PTCT's peers: BBIO (BridgeBio Pharma), BMRN (BioMarin), CAPR (Capricor), DYN (Dyne Therapeutics), IONS (Ionis Pharmaceuticals), KRYS (Krystal Biotech), RARE (Ultragenyx), SLDB (Solid Biosciences).
Updated 2026-11-03 00:47 UTC